DNA methyltransferases, DNA damage repair, and cancer - PubMed
Review
DNA methyltransferases, DNA damage repair, and cancer
Bilian Jin et al. Adv Exp Med Biol. 2013.
Abstract
The maintenance DNA methyltransferase (DNMT) 1 and the de novo methyltransferases DNMT3A and DNMT3B are all essential for mammalian development. DNA methylation, catalyzed by the DNMTs, plays an important role in maintaining genome stability. Aberrant expression of DNMTs and disruption of DNA methylation patterns are closely associated with many forms of cancer, although the exact mechanisms underlying this link remain elusive. DNA damage repair systems have evolved to act as a genome-wide surveillance mechanism to maintain chromosome integrity by recognizing and repairing both exogenous and endogenous DNA insults. Impairment of these systems gives rise to mutations and directly contributes to tumorigenesis. Evidence is mounting for a direct link between DNMTs, DNA methylation, and DNA damage repair systems, which provide new insight into the development of cancer. Like tumor suppressor genes, an array of DNA repair genes frequently sustain promoter hypermethylation in a variety of tumors. In addition, DNMT1, but not the DNMT3s, appear to function coordinately with DNA damage repair pathways to protect cells from sustaining mutagenic events, which is very likely through a DNA methylation-independent mechanism. This chapter is focused on reviewing the links between DNA methylation and the DNA damage response.
Figures

DNMT1 may promote stabilization of microsatellites via methylation of CpG repeats and it also interacts with DNA repair proteins via third-party mediators (e.g. MBD4 and PCNA). Moreover, deficiency in DNMT1 leads to activation of PARP signaling, eventually resulting in MMR protein cleavage. DNMT1 is also closely associated with DDR. Inactivation of DNMT1 may induce several changes to DNA and/or chromatin including increased DNA fragility, disruption of replication foci, and accumulation of hemimethylated DNA, which may be recognized as “damage” and activate the DDR. Strong support for a direct link between DNMT1 and DDR comes from the identification of several protein-protein interactions involving DNMT1 and DDR proteins. DNMT1 is recruited to sites of DNA damage via its interaction with PCNA and 9-1-1. DNMT1 is also capable of binding CHK1 and p53, which promote cell cycle arrest and apoptosis, respectively.
Similar articles
-
Yoshikawa H. Yoshikawa H. Gan To Kagaku Ryoho. 2007 Feb;34(2):145-9. Gan To Kagaku Ryoho. 2007. PMID: 17301518 Review. Japanese.
-
DNA Methyltransferase Inhibitors and their Therapeutic Potential.
Zhou Z, Li HQ, Liu F. Zhou Z, et al. Curr Top Med Chem. 2018;18(28):2448-2457. doi: 10.2174/1568026619666181120150122. Curr Top Med Chem. 2018. PMID: 30465505 Review.
-
[DNA methyltransferases: classification, functions and research progress].
Wang ZG, Wu JX. Wang ZG, et al. Yi Chuan. 2009 Sep;31(9):903-12. doi: 10.3724/sp.j.1005.2009.00903. Yi Chuan. 2009. PMID: 19819843 Review. Chinese.
-
Lopatina N, Haskell JF, Andrews LG, Poole JC, Saldanha S, Tollefsbol T. Lopatina N, et al. J Cell Biochem. 2002;84(2):324-34. doi: 10.1002/jcb.10015. J Cell Biochem. 2002. PMID: 11787061
-
Lin RK, Hsu HS, Chang JW, Chen CY, Chen JT, Wang YC. Lin RK, et al. Lung Cancer. 2007 Feb;55(2):205-13. doi: 10.1016/j.lungcan.2006.10.022. Epub 2006 Nov 30. Lung Cancer. 2007. PMID: 17140695
Cited by
-
Liu Z, Zhou T, Gao D. Liu Z, et al. Front Genet. 2022 Nov 2;13:994471. doi: 10.3389/fgene.2022.994471. eCollection 2022. Front Genet. 2022. PMID: 36406125 Free PMC article. Review.
-
Weinguny M, Eisenhut P, Klanert G, Virgolini N, Marx N, Jonsson A, Ivansson D, Lövgren A, Borth N. Weinguny M, et al. Biotechnol Bioeng. 2020 Nov;117(11):3435-3447. doi: 10.1002/bit.27493. Epub 2020 Jul 24. Biotechnol Bioeng. 2020. PMID: 32662873 Free PMC article.
-
Opare-Addo PA, Sarfo FS, Aikins M, Bediako SA, Ovbiagele B. Opare-Addo PA, et al. J Stroke Cerebrovasc Dis. 2024 May;33(5):107585. doi: 10.1016/j.jstrokecerebrovasdis.2024.107585. Epub 2024 Jan 20. J Stroke Cerebrovasc Dis. 2024. PMID: 38253246
-
Brezgin S, Kostyusheva A, Bayurova E, Gordeychuk I, Isaguliants M, Goptar I, Nikiforova A, Smirnov V, Volchkova E, Glebe D, Kostyushev D, Chulanov V. Brezgin S, et al. Microorganisms. 2019 Nov 6;7(11):533. doi: 10.3390/microorganisms7110533. Microorganisms. 2019. PMID: 31698767 Free PMC article.
-
Li Y, Gan Y, Liu J, Li J, Zhou Z, Tian R, Sun R, Liu J, Xiao Q, Li Y, Lu P, Peng Y, Peng Y, Shu G, Yin G. Li Y, et al. Signal Transduct Target Ther. 2022 Mar 30;7(1):87. doi: 10.1038/s41392-022-00902-6. Signal Transduct Target Ther. 2022. PMID: 35351858 Free PMC article.
References
-
- Robertson KD. DNA methylation and human disease. Nat Rev Genet. 2005 Aug;6(8):597–610. - PubMed
-
- Kareta MS, Botello ZM, Ennis JJ, Chou C, Chedin F. Reconstitution and mechanism of the stimulation of de novo methylation by human DNMT3L. J Biol Chem. 2006 Sep 8;281(36):25893–25902. - PubMed
-
- Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999 Oct 29;99(3):247–257. - PubMed
-
- Okano M, Xie S, Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet. 1998 Jul;19(3):219–220. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases